In the present study, chronic peripheral AChE inhibition via pyridostigmine showed compelling antioxidative, anti-inflammatory, and antifibrotic effects, with the subsequent preservation of cardiac functional parameters in a rat model of CHF. Here, ACHE is linked to congestive heart failure.